Table 3 Diagnoses and treatments received

Diagnoses

-

Ductal Carcinoma In Situ (DCIS)

15

11.3

Localized breast cancer

108

81.2

Metastatic breast cancer

5

3.8

Inflammatory breast cancer

 < 5

0.8

Other including second primary

 < 5

3.0%

Treatment to the Breast

1 (0.8%)

Lumpectomy alone

 < 5

0.7%

Lumpectomy and radiation

57

42.9%

Mastectomy alone

28

21.1%

Mastectomy and radiation

35

26.3%

Lumpectomy and mastectomy alone

 < 5

2.3%

Lumpectomy, mastectomy and radiation

7

5.3%

Double mastectomy

 < 5

0.8%

Reconstruction after mastectomy (n = 73)

-

No

40

54.8%

Immediate

16

21.9%

Delayed

17

23.3%

Treatment to the Axilla (n = 71)

 < 5 (5.6%)

Sentinel node biopsy only

7

9.9%

Axillary dissection ± Sentinel node biopsy

25

35.2%

Axillary dissection ± Sentinel node biopsy + radiation

34

47.9%

Radiation only

 < 5

1.4%

Intravenous Systemic Therapy

Chemotherapy without Herceptin

73

54.9%

Herceptin only

 < 5

1.5%

Chemotherapy + Herceptin

24

18.0%

None/not reported

34

25.6%

Hormonal Treatments

Tamoxifen alone

25

18.8%

Aromatase inhibitors alone

18

13.5%

Other/combination

 < 5

3.0%

None/not reported

86

64.7%

Current use of hormone therapy

Yes

52

39.1%